What? When? Why?

Latest Happenings in Business World

Share on

Dec-2021

Cell Surface Markers Market Size To Grow USD 973 Mn By 2026

Global Cell Surface Markers Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Source, Cell Type, End-User & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

As per our research report, the size of global cell surface markers market size was worth USD 659.1 million in 2021. The market is expected to reach USD 973.83 million in 2026, at a CAGR of 8.12% over the forecast period.

The COVID-19 pandemic is expected to impact the cell surface markers market significantly. Many research projects are underway and involve the interaction of COVID-19 antibodies with cell surface markers in the action of immune response seen in the body. The studies found a higher rate of fungal co-infections during COVID-19 in patients, and especially severe high-risk infection called ‘mucormycosis’. In addition, the rate of secondary fungal infections is increasing in many COVID-19 patients due to their reduced immunity and high use of immune suppressant drugs. Initiatives contributed to a better understanding of the disease, leading to innovative ways to find a cure. Other such research projects and growing awareness are expected to drive the growth of the cell surface markers market.

Over the past several years, the global cell surface markers market has experienced significant growth, attributed to the increased rate of cancers and other autoimmune diseases. This increase in cancer has stimulated the demand to develop innovative diagnostic procedures to identify diseases and treat them. According to the Globocan 2020 report, the total number of breast cancers in 2020 was 2,261,420, followed by lung cancer with 2,206,775 cases and prostate cancer with 1,414,260 cases. Because cell surface markers serve as indicators to help identify and classify cells, proteins expressed on the surface of cancer cells serve as markers for specific tumor types.

The increasing rate of autoimmune diseases and cancer has also overburdened the healthcare sector globally, especially in developing countries. As a result, there is significant emphasis on minimizing the cost of disease diagnosis to reduce the overall cost per person. This emphasis on reducing the cost of disease diagnosis positively impacts the cell surface markers market as it is an efficient and inexpensive way to identify autoimmune health conditions. Furthermore, in addition to the factor mentioned above, spending on technological advancements in the healthcare sector has increased in recent years. Therefore, the rise of technological advances in healthcare will also drive the growth of the studied market.

However, high prices associated with cell markers for their products and instruments have limited the market's growth. Further market consolidation, simplification of analytical products, laboratory maintenance, skilled labor, and the introduction of cheaper products will have a negative impact on the cell surface markers market in the years to come.

KEY MARKET INSIGHTS:

Based on antibodies by source, the mouse segment is projected to account for most of the global cell surface markers market during the forecast period. Furthermore, it is to have the highest CAGR during the forecast period, mainly due to the reduced costs of mouse models as a source of antibody production.
Based on end-users, in 2020, the academic and research institute segment accounted for most of the market. Factors such as increasing use of cell surface markers in cancer, stem cell, and HIV research and improved public-private funding for research based on cell surface markers will drive the growth of this segment.

Based on region, in 2020, North America dominated the market with 36% of the market share and is predicted to grow at a CAGR of 7.95% during the forecast period. This regional market will grow owing to the increased use of cell surface markers in precision medicine, rising R&D activities, and focus on drug discovery and development. In addition, the high incidence and prevalence of cancer and continuous and ongoing research projects carried out in this region are contributing to its market share. Europe is predicted to have prominent growth due to market leaders in this region, which contributes to the market share. Over the analysis period, the Asia-Pacific region will experience the highest growth rate of 8.95% due to a significant increase in R&D investments and unmet medical and health needs.
The leading players focus on collaborations with other entities present in the market, such as academic research institutes and laboratories, focusing on their R&D to produce cell-specific antibodies. Key players are focusing on the untapped market to maintain their position. Mergers and acquisitions will help companies quicken their product development and launches, thereby assisting the growing companies operating in this market.
Notable players in the global cell surface markers market include Bio-Rad Laboratories, Inc., Siemens Healthcare Private Limited, Beckman Coulter, Inc., NIHON KOHDEN CORPORATION, Hoffmann-La Roche Ltd, BD, Abcam PLC., QIAGEN, Thermo Fisher Scientific, Abbott, Danaher, GenScript, Merk KGaA, BioLegend, Inc. and Cell Signaling Technology, Inc.

MARKET SEGMENTATION:

By Type: